Determination of Molecular Status, as Well as the Efficacy and Safety of Fluorodeoxyglucose (18F-FDG) in PET-CT Imaging in Juvenile Patients With Histiocytosis

Condition:   Histiocytosis Intervention:   Drug: fluorodeoxyglucose (18F-FDG) Sponsors:   Anna Raciborska;   Maria Sklodowska-Curie Institute - Oncology Center;   Łukasiewicz Research Network;   Wrocław University of Environmental and Life Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials